KR20100003074A - 기능성 소금 및 이의 제조방법 - Google Patents
기능성 소금 및 이의 제조방법 Download PDFInfo
- Publication number
- KR20100003074A KR20100003074A KR1020080063175A KR20080063175A KR20100003074A KR 20100003074 A KR20100003074 A KR 20100003074A KR 1020080063175 A KR1020080063175 A KR 1020080063175A KR 20080063175 A KR20080063175 A KR 20080063175A KR 20100003074 A KR20100003074 A KR 20100003074A
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- weight
- bamboo
- content
- mixture
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 182
- 238000000034 method Methods 0.000 title claims abstract description 41
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 41
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 41
- 241001330002 Bambuseae Species 0.000 claims abstract description 41
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 41
- 239000011425 bamboo Substances 0.000 claims abstract description 41
- 239000000203 mixture Substances 0.000 claims abstract description 36
- 238000010438 heat treatment Methods 0.000 claims abstract description 26
- 230000037303 wrinkles Effects 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 230000003078 antioxidant effect Effects 0.000 claims description 52
- 239000003963 antioxidant agent Substances 0.000 claims description 42
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 35
- 239000002537 cosmetic Substances 0.000 claims description 27
- 239000011780 sodium chloride Substances 0.000 claims description 18
- 239000004480 active ingredient Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 230000009759 skin aging Effects 0.000 abstract description 10
- 230000002000 scavenging effect Effects 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 description 174
- 235000006708 antioxidants Nutrition 0.000 description 41
- 210000003491 skin Anatomy 0.000 description 25
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 239000000523 sample Substances 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- 239000011707 mineral Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 235000021395 porridge Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- -1 For example Substances 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 239000005445 natural material Substances 0.000 description 4
- 229910017604 nitric acid Inorganic materials 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102100039300 Phosphatidylserine synthase 2 Human genes 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 101100464927 Bacillus subtilis (strain 168) ppsB gene Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 101100288173 Enterococcus faecalis (strain ATCC 700802 / V583) prs1 gene Proteins 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 101100465401 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SCL1 gene Proteins 0.000 description 2
- 101710138332 Somatostatin-2 Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 101150016674 prs2 gene Proteins 0.000 description 2
- 235000015598 salt intake Nutrition 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- QLOKJRIVRGCVIM-UHFFFAOYSA-N 1-[(4-methylsulfanylphenyl)methyl]piperazine Chemical compound C1=CC(SC)=CC=C1CN1CCNCC1 QLOKJRIVRGCVIM-UHFFFAOYSA-N 0.000 description 1
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 1
- FJERMCQUSONQAU-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1h-triazine Chemical compound N1N(C=2N=CC=CC=2)N=C(C=2N=CC=CC=2)C=C1C1=CC=CC=N1 FJERMCQUSONQAU-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 102100039298 Phosphatidylserine synthase 1 Human genes 0.000 description 1
- 101710116266 Phosphatidylserine synthase 1 Proteins 0.000 description 1
- 101710116267 Phosphatidylserine synthase 2 Proteins 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000006318 protein oxidation Effects 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Step | Temp(℃) | Step duration in h : min | Temp-min (℃/min) | Temp gradient type |
1 | 200 | 01:40 | 2 | Gradient |
2 | 400 | 00:50 | 4 | Gradient |
3 | 1,100 | 02:55 | 4 | Gradient |
4 | 1,100 | 00:30 | - | Step-n-hold |
Sample name1) | DDW | PBS | ||
pH | ORP (mV) | pH | ORP (mV) | |
P-RS(1) | 9.17 | 15 | 6.83 | 78 |
P-RS(2) | 10.66 | -239 | 7.22 | -243 |
P-RS(3) | 9.66 | -48 | 6.88 | 42 |
P-SS(1) | 9.32 | 135 | 6.84 | 72 |
P-SS(2) | 10.21 | -225 | 7.04 | -206 |
P-SS(3) | 9.82 | -79 | 7.11 | -20 |
P-PS(1) | 8.36 | 170 | 6.84 | 83 |
P-PS(2) | 10.52 | -236 | 7.29 | -249 |
P-PS(3) | 9.92 | -37 | 7.06 | 20 |
P-RS | 8.77 | 78 | 7.0 | 60 |
P-SS | 9.06 | 102 | 6.94 | 87 |
P-PS | 5.75 | 173 | 7.06 | 95 |
RS | 10.55 | 20 | 7.58 | 42 |
SS | 8.05 | 88 | 7.09 | 92 |
PS | 6.1 | 120 | 7.09 | 106 |
BS | 11.12 | -128 | 7.76 | -128 |
PBS | 10.66 | -224 | 7.24 | -243 |
Sample | Major elements(ppm) | minor elements(ppm) | NaCl (%) | ||||||||||
Na | K | Cl (Cl- ion) | Ca | Mg | S (SO4 2 - ion) | Fe | Zn | Cu | Mn | Sr | Br (ion) | ||
PPS2 | 373,000 | 1,265 | 574,690 | 95 | 14,971 | 6,716 | 17.79 | 1.54 | 1.88 | 3.62 | 0.30 | 368 | 88.3 |
PSS2 | 387,000 | 5,576 | 605,557 | 1,643 | 12,211 | 1,714 | 20.77 | 1.95 | 1.83 | 7.41 | 7.16 | 704 | 94.9 |
PRS2 | 387,750 | 4,606 | 599,550 | 1,942 | 12,146 | 2,628 | 33.42 | 2.02 | 1.67 | 6.63 | 7.58 | 546 | 93.6 |
시료명 | 시약급 소금(PS) | 대나무 첨가 | MgSO4 | 죽력 | 표준화 굽기과정 | pH (in DDW) | ORP (in PBS) | 비교 |
PS | ○ | - | - | - | - | 6.1 | 106 | 비처리 대조군 |
PPS | ○ | - | - | - | ○ | 5.75 | 95 | 부재료무첨가군 |
PPS-1 | ○ | - | ○ | ○ | ○ | 8.36 | 83 | 부재료첨가군 |
PPS-2 | ○ | ○ | - | - | ○ | 10.52 | -249 | 부재료첨가군 |
PPS-3 | ○ | ○ | ○ | - | ○ | 9.92 | 20 | 분재료첨가군 |
시료명 | 시약급 소금(PS) | 대나무 첨가 | MgSO4 | 죽력 | 표준화 굽기과정 | pH (in DDW) | ORP (in PBS) | 비교 |
SS | ○ | - | - | - | - | 8.05 | 92 | 비처리 대조군 |
PSS | ○ | - | - | - | ○ | 9.06 | 87 | 부재료무첨가군 |
PSS-1 | ○ | - | ○ | ○ | ○ | 9.32 | 72 | 부재료첨가군 |
PSS-2 | ○ | ○ | - | - | ○ | 10.21 | -206 | 부재료첨가군 |
PSS-3 | ○ | ○ | ○ | - | ○ | 9.82 | -20 | 분재료첨가군 |
시료명 | 시약급 소금(PS) | 대나무 첨가 | MgSO4 | 죽력 | 표준화 굽기과정 | pH (in DDW) | ORP (in PBS) | 비교 |
RS | ○ | - | - | - | - | 10.55 | 7.58 | 비처리 대조군 |
PRS | ○ | - | - | - | ○ | 8.77 | 7.0 | 부재료무첨가군 |
PRS-1 | ○ | - | ○ | ○ | ○ | 9.17 | 78 | 부재료첨가군 |
PRS-2 | ○ | ○ | - | - | ○ | 10.66 | -243 | 부재료첨가군 |
PRS-3 | ○ | ○ | ○ | - | ○ | 9.66 | 42 | 분재료첨가군 |
Samples | DPPH radical scavenging activity (IC50) |
PS | ND |
SS | ND |
RS | ND |
BS | 〈100 |
PBS | 8.75 |
PPS2 | 4.24 |
PSS2 | 22.15 |
PRS2 | 3.49 |
Claims (6)
- a) 소금과 대나무를 중량비를 기준으로 40:60 내지 70:30(소금:대나무)으로 혼합하는 단계;b) 상기 소금과 대나무 혼합물을 4 내지 6시간 동안 가열하여, 상기 혼합물이 1,100℃가 될 때까지 가열하는 제1 열처리 단계; 및c) 상기 제1 열처리 단계를 수행한 혼합물을 1,100℃에서 15분 내지 60분 동안 열처리하는 제2 열처리 단계를 포함하는 항산화능이 개선된 소금의 제조방법.
- 제1항에 있어서, 상기 소금은 천일염 또는 정제염인 항산화능이 개선된 소금의 제조방법.
- 제2항에 있어서, 상기 a) 단계 전에 상기 천일염을 750 내지 850℃에서 12시간 내지 36시간 동안 열처리하는 전처리 단계를 추가로 포함하는 항산화능이 개선된 소금의 제조방법.
- 제1항 내지 제3항 중 어느 한 항의 제조방법에 의해 제조된 소금.
- 제4항에 있어서, 상기 소금은 소금 전체 중량을 기준으로, 염화나트륨 함량 이 80 내지 99중량%이고, 칼슘 함량이 0.1 내지 0.28 중량%이며, 칼륨 함량이 0.1 내지 0.6 중량%이고, 마그네슘 함량이 0.8 내지 1.8 중량%이며, 황 함량이 0.1 내지 0.8 중량%인 소금.
- 제4항의 소금을 유효성분으로 포함하는 피부 주름 및 탄력 개선용 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080063175A KR101043806B1 (ko) | 2008-06-30 | 2008-06-30 | 기능성 소금 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080063175A KR101043806B1 (ko) | 2008-06-30 | 2008-06-30 | 기능성 소금 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100003074A true KR20100003074A (ko) | 2010-01-07 |
KR101043806B1 KR101043806B1 (ko) | 2011-06-22 |
Family
ID=41813030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080063175A KR101043806B1 (ko) | 2008-06-30 | 2008-06-30 | 기능성 소금 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101043806B1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101347324B1 (ko) * | 2011-11-14 | 2014-01-06 | (주) 메디플랜 | 피부 노화 방지 효과가 있는 오배자 염 및 이의 제조방법 |
KR101357792B1 (ko) * | 2012-06-27 | 2014-02-03 | 청수식품주식회사 | 황산염을 이용한 미네랄죽염의 제조방법 및 그에 의하여 제조된 미네랄죽염 |
KR101383888B1 (ko) * | 2012-05-14 | 2014-04-10 | 한국농어촌공사 | 황토 용기를 이용한 미네랄 죽염의 제조방법 및 그에 의하여 제조된 미네랄죽염 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950026509A (ko) * | 1994-03-21 | 1995-10-16 | 우영근 | 피부 맛사아지 미용용 죽염 제조방법 |
KR100234818B1 (ko) * | 1995-12-29 | 1999-12-15 | 성재갑 | 화장료 조성물 |
KR100453206B1 (ko) | 2001-05-21 | 2004-10-15 | 김종대 | 죽염제조방법 |
KR100512201B1 (ko) | 2002-07-08 | 2005-09-02 | 청학동삼선당주식회사 | 녹차를 함유한 신규한 죽염 조성물 |
-
2008
- 2008-06-30 KR KR1020080063175A patent/KR101043806B1/ko active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101347324B1 (ko) * | 2011-11-14 | 2014-01-06 | (주) 메디플랜 | 피부 노화 방지 효과가 있는 오배자 염 및 이의 제조방법 |
KR101383888B1 (ko) * | 2012-05-14 | 2014-04-10 | 한국농어촌공사 | 황토 용기를 이용한 미네랄 죽염의 제조방법 및 그에 의하여 제조된 미네랄죽염 |
KR101357792B1 (ko) * | 2012-06-27 | 2014-02-03 | 청수식품주식회사 | 황산염을 이용한 미네랄죽염의 제조방법 및 그에 의하여 제조된 미네랄죽염 |
Also Published As
Publication number | Publication date |
---|---|
KR101043806B1 (ko) | 2011-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105055251B (zh) | 一种抗衰老化妆品及其制备方法 | |
KR101219520B1 (ko) | 항염증, 항산화 또는 항세균 조성물 | |
KR101682394B1 (ko) | 컬러푸드 추출복합물을 함유하는 화장료 조성물 | |
CN107496307A (zh) | 一种美白补水面膜 | |
KR101337454B1 (ko) | 피부보습 및 진정효과를 갖는 해양성 온천수 조성물 및 이의 제조방법 | |
CN104434642B (zh) | 一种晒后修护美白保湿凝露及其制备方法 | |
CN106074317A (zh) | 蓝莓口红及其制备方法 | |
KR101043806B1 (ko) | 기능성 소금 및 이의 제조방법 | |
KR101397160B1 (ko) | 선복화, 백미 및 영릉향을 이용한 두피 자극완화용 화장료 조성물 | |
KR20090099110A (ko) | 나노 은이 함유된 기능성 영양 크림 | |
WO2015010371A1 (zh) | 一种用于治疗青春痘色素沉斑和美白的精华液 | |
KR20120068220A (ko) | 초석잠 추출물을 함유하는 주름개선용 한방화장료 조성물 제조방법 및 이로부터 제조된 한방화장료 조성물 | |
BG67506B1 (bg) | Хранителна добавка, базирана на комбинация екстракти от череша, вишна и японска вишна с натурален антиоксидантен състав | |
KR20060093164A (ko) | 주름완화 화장료 조성물 | |
KR101675062B1 (ko) | 멜라토닌을 이용한 이중 코팅된 순수 비타민 c 및 이를 함유하는 화장료 조성물 | |
KR20090105225A (ko) | 피부 노화 방지용 화장료 조성물 | |
CN107802570A (zh) | 一种亮颜补水面膜 | |
KR101550275B1 (ko) | 거북으로부터 아교를 제조하는 방법 및 그 아교를 함유하는 피부개선용 화장료 조성물 | |
KR20180110357A (ko) | 옥정수와 연옥분말을 유효성분으로 포함하는 산화적 스트레스 억제 활성을 갖는 화장료 조성 | |
CN106137936A (zh) | 蓝莓精华护肤液及其制备方法 | |
KR20130052288A (ko) | 연의 온천수 추출물을 유효성분으로 포함하는 화장료 조성물 | |
CN106619368A (zh) | 一种美白保湿抗皱的芦荟珍珠面膜 | |
KR101108710B1 (ko) | 한방 국화조성물과 이를 이용한 바디 및 두피 클렌져의 제조방법 | |
KR20100090533A (ko) | 보령산 머드 추출물의 추출방법 및 그 추출물을 함유하는 미백기능성 화장료 조성물 | |
CN109820785A (zh) | 一种抗皱祛斑美白膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140617 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150616 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160616 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170613 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180530 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190530 Year of fee payment: 9 |